Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Smith

Showing results (1-10 of 138) with videos related to

Pageof 14
Sort By:
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|March 10, 2007
Forgotten specialtyAlan Smith
Scientific Reports|May 11, 2021
Macrosynteny analysis between Lentinula edodes and Lentinula novae-zelandiae reveals signals of domestication in Lentinula edodesChristopher Alan Smith
Expert Opinion on Pharmacotherapy|December 8, 2006
Dextromethorphan/quinidine: a novel dextromethorphan product for the treatment of emotional labilityRichard Alan Smith
Degenerative Neurological and Neuromuscular Disease|July 28, 2018
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosisMichael Hinchcliffe, Alan Smith
Expert Opinion on Drug Delivery|November 22, 2005
TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tractPeter Watts, Alan Smith
Wellcome Open Research|August 8, 2024
The genome sequence of the nine-spined stickleback, <i>Pungitius pungitius</i> (Linnaeus, 1758)Bernd Hänfling, Alan Smith, , et al.
Expert Opinion on Drug Delivery|May 6, 2009
PecSys: in situ gelling system for optimised nasal drug deliveryPeter Watts, Alan Smith
New Directions for Youth Development|September 9, 2004
Challenging intoleranceAlan Smith, Ciarán O Maoláin
Drug Design, Development and Therapy|January 6, 2017
Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosisAnn Margaret Dyer, Alan Smith
Drug Discovery Today|November 16, 2010
Re-formulating drugs and vaccines for intranasal delivery: maximum benefits for minimum risks?Peter J Watts, Alan Smith
Pageof 14

Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Nursing Standard (Royal College of Nursing (Great Britain) : 1987)|March 10, 2007
Forgotten specialtyAlan Smith
Scientific Reports|May 11, 2021
Macrosynteny analysis between Lentinula edodes and Lentinula novae-zelandiae reveals signals of domestication in Lentinula edodesChristopher Alan Smith
Expert Opinion on Pharmacotherapy|December 8, 2006
Dextromethorphan/quinidine: a novel dextromethorphan product for the treatment of emotional labilityRichard Alan Smith
Degenerative Neurological and Neuromuscular Disease|July 28, 2018
Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosisMichael Hinchcliffe, Alan Smith
Expert Opinion on Drug Delivery|November 22, 2005
TARGIT technology: coated starch capsules for site-specific drug delivery into the lower gastrointestinal tractPeter Watts, Alan Smith
Wellcome Open Research|August 8, 2024
The genome sequence of the nine-spined stickleback, <i>Pungitius pungitius</i> (Linnaeus, 1758)Bernd Hänfling, Alan Smith, , et al.
Expert Opinion on Drug Delivery|May 6, 2009
PecSys: in situ gelling system for optimised nasal drug deliveryPeter Watts, Alan Smith
New Directions for Youth Development|September 9, 2004
Challenging intoleranceAlan Smith, Ciarán O Maoláin
Drug Design, Development and Therapy|January 6, 2017
Riluzole 5 mg/mL oral suspension: for optimized drug delivery in amyotrophic lateral sclerosisAnn Margaret Dyer, Alan Smith
Drug Discovery Today|November 16, 2010
Re-formulating drugs and vaccines for intranasal delivery: maximum benefits for minimum risks?Peter J Watts, Alan Smith
Pageof 14